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Abstract
Background: Alzheimer’s disease (AD) is common among older adults and leads to significant disability. Volatile
anesthetic gases administered during general anesthesia (GA) have been hypothesized to be a risk factor for the
development of AD. The objective of this study is to systematically review the association between exposure to GA
and risk of AD.
Methods: We searched electronic databases including MEDLINE, Embase, and Google scholar for observational
studies examining the association between exposure to GA and risk of AD. We examined study quality using a
modified version of the Newcastle-Ottawa risk of bias assessment for observational studies. We used standard
meta-analytic techniques to estimate pooled odds ratios (OR) and 95% confidence intervals (CI). Subgroup and
sensitivity analyses were undertaken to evaluate the robustness of the findings.
Results: A total of 15 case-control studies were included in the review. No cohort studies were identified that met
inclusion criteria. There was variation in the methodological quality of included studies. There was no significant
association between any exposure to GA and risk of AD (pooled OR: 1.05; 95% CI: 0.93 - 1.19, Z = 0.80, p = 0.43).
There was also no significant association between GA and risk of AD in several subgroup and sensitivity analyses.
Conclusions: A history of exposure to GA is not associated with an increased risk of AD although there are few
high-quality studies in this area. Prospective cohort studies with long-term follow-up or randomized controlled
trials are required to further understand the association between GA and AD.
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Background
Alzheimer’s disease (AD) and related forms of dementia
affect 13% of all adults over age 65 and the number of
individuals with dementia in the United States is
expected to increase from a current prevalence of 5.1
million to over 7.7 million individuals by 2030[1]. The
effects of AD on society are substantial. In the United
States the annual direct costs associated with AD are
$148 billion and caregivers provide 8.5 billion hours of
care annually[1]. Alzheimer’s disease is also a leading
reason for admission to long-term care facilities.
The pathophysiology of AD involves the accumulation
of protein plaques composed of b-amyloid and the
formation of neurofibrillary tangles related to hyperpho-
sphorylation of tau proteins[2]. The cause of AD is
multi-factorial with some of the strongest risk factors
for AD include advanced age, female gender, educational
achievement, family history and specific genetic muta-
tions[3]. There are few modifiable risk factors which
have been identified for AD, which include a history of
head trauma and most cardiovascular risk factors[3].
Short-term cognitive dysfunction lasting days to weeks
has been commonly observed following surgery[4] and
is often referred to as postoperative cognitive dysfunc-
tion (POCD). Recently, some potential mechanisms link-
ing inhaled volatile anesthetics to AD pathology have
been proposed to provide a link between exposure to
general anesthesia (GA) and the subsequent develop-
ment of POCD or AD following surgery[5]. Commonly
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increase the formation of AD precursors including b-
amyloid plaques[6,7], and neurofibrillary tangles[8,9] in
animal models and in vitro studies. However, rando-
mized controlled trials have failed to demonstrate an
increased risk of persistent cognitive impairment in the
1 - 2 years following exposure to GA when compared to
regional anesthesia[10]. To date there have been no ran-
domized controlled trials that have examined the risk of
developing cognitive impairment meeting clinical criteria
for AD or related forms of dementia associated with
exposure to GA. There have been previous narrative
reviews on the potential relationship between anesthesia
and POCD[11,12] and systematic reviews which have
examined the relationship between GA and postopera-
tive delirium or POCD[13-17]. Most reviews found that
there was limited evidence to suggest any difference
between GA anesthesia and regional anesthesia on the
incidence of post-operative delirium or POCD
[13,15-17]. One exception was a review on anesthesia
for hip fracture surgery which found a reduction in
acute postoperative confusion for regional anesthesia
compared to GA [14]. To date there are no reviews that
have examined whether exposure to GA is a risk factor
for the development of AD. Therefore, the objective of
our study is to systematically review the literature on
observational studies examining the association between
exposure to GA and subsequent development of AD.
Understanding the risk of AD associated with exposure
to GA would help in determining the relationship
between GA and AD and inform strategies to prevent
or minimize the risk of AD following surgical
procedures.
Methods
Search strategy
We searched MEDLINE, EMBASE, and Google Scholar
using key words and medical subject headings to iden-
tify relevant articles (see Additional File 1, Document 1).
The reference lists of retrieved articles were hand-
searched for additional references. There were no lan-
guage restrictions and data from both published and
unpublished studies were included provided that suffi-
cient information was available for data extraction. Two
authors (DS and NS) were involved in the selection of
studies for the review and discrepancies were resolved
by discussion after retrieving the full text of articles in
question.
Types of studies
We followed the MOOSE[18] and PRISMA[19] guide-
lines for the reporting of meta-analysis of observational
studies. Observational studies examining exposure to
GA and risk of AD including both case-control and
cohort studies were eligible for the review. We included
human studies where the mean age of study population
was ≥ 50 years of age. We excluded studies that exam-
ined POCD, postoperative delirium, or abnormalities on
neuropsychological testing without a diagnosis of
dementia from the review to focus only on the outcome
of development of AD.
Definition of exposure
Exposure to GA was defined as any reported history of
surgery under GA when compared to no history of sur-
gery under GA. Where information was available, the
following information was also recorded: history of
exposure to GA when compared to regional anesthesia
(RA); the number of previous GAs; cumulative exposure
to GA as measured in minutes of GA exposure; the type
of surgery performed under GA (cardiovascular, non-
cardiovascular, or neurological); the type of agent uti-
lized for GA; and, duration of time between exposure to
GA and assessment for AD.
Definition of Outcomes
T h ep r i m a r yo u t c o m ew a sad i a g n o s i so fA Do fa n y
severity according to clinical impression or standard AD
diagnostic criteria. These AD criteria included: National
Institutes of Neurological and Communicative Disorders
and Stroke - Alzheimer’s Disease and Related Disorders
(NINDS-ADRDA)[20]; Diagnostic and Statistical Manual
of Mental Disorders (DSM)[21]; or the International
Classification of Diseases. Secondary outcomes included
time to development of AD, and the development of
early-onset (<65 years) or late-onset AD (>65 years).
Data extraction
Two reviewers (DS and NS) extracted data from
included studies using a standard data extraction form.
Information extracted from studies included: age of par-
ticipants, gender distribution, source population and
description of sample selection methods. We also
recorded potential confounders including medical mor-
bidity and indication for surgery. For case-control stu-
dies, we recorded the number of cases and controls with
exposure to GA and the summary odds ratio (OR) and
95% confidence intervals (CI) reported in studies from
matched or adjusted analyses.
Assessment of Study Quality
Primary studies were reviewed according to the
STROBE criteria[22] and study quality checklist based
on the Newcastle-Ottawa criteria for case-control and
cohort studies was developed[23] to describe potential
risk of bias according to seven aspects of study quality
(see Additional File 2, Document 2). We classified case-
control studies as being at overall high or low risk of
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risk of bias if all of the following study quality items
were recorded as low risk of bias: definition of cases,
sample used for selection of controls, and matching or
adjusting for a minimum of age and gender.
Data Synthesis and Meta-Analysis
We included a qualitative description of studies meeting
inclusion criteria using text and tables. Studies were first
assessed qualitatively for homogeneity and homogeneous
studies were combined in meta-analysis to arrive at (OR)
and 95% confidence intervals (CI) for the association
between GA and AD. We combined case-control studies
that controlled for a minimum of both age and gender
either through matching or statistical adjustment. When
multiple control groups were used in a study we only
included the control group that was most representative
of the source population for meta-analysis. Random
effects models were utilized for all meta-analyses given
the expected heterogeneity between different studies.
Study weights were assigned using the inverse of the
study variance. The software package Comprehensive
Meta-Analysis (version 2.2) was utilized for all analyses.
Heterogeneity
We assessed study heterogeneity qualitatively by asses-
sing study populations and study designs. We assessed
statistical heterogeneity quantitatively using the Cochran
Q statistic and used p-values of ≤0.1 as our threshold
for heterogeneity. We used the I
2 statistic to quantify
the degree of statistical heterogeneity.
Subgroup and Sensitivity Analysis
We planned to analyse case-control and cohort studies
were separately. We planned to undertake the following
subgroup analyses: by control group (no surgery control
groups or regional anesthesia control groups); high and
low risk of bias studies; AD diagnosis (standard AD cri-
teria compared to clinical criteria or other methods of
diagnosis); and, type of surgery (non-cardiac surgery, neu-
rological, or cardiac surgery). We also examined the sum-
mary OR for exposure to any GA after excluding each
study sequentially to evaluate for studies that may have
had a large influence on the results of the meta-analysis.
We also conducted a meta-regression of the association
between the reported OR for GA exposure and risk of AD
using year of publication as an independent variable as
older anesthestic agents may be associated with a greater
risk of AD when compared to newer anesthetics[6].
Publication Bias
We assessed the potential publication bias by visual
inspection of the funnel plot produced by plotting the
standard error against the log OR of studies.
Results
Study Selection
The flow of studies through the review process is out-
lined in Figure 1. A total of 15 case-control studies were
identified that met inclusion criteria[24-38]. Fourteen of
the included studies were published as full manuscripts
and one was presented in poster form at a conference
[37]. There were no cohort studies that met our inclu-
sion criteria.
Description of Included Studies
The characteristics of the included studies are described
in (see Additional File 3, Table S1). A total of 1,752
cases and 5,261 controls were included in the respective
studies. Cases and controls in most studies were com-
parable in terms of age and gender distribution. Ten
studies used matching to control for potential confound-
ing related to age and gender with the remaining 5 stu-
dies using statistical adjustment for these factors. Eight
studies determined exposure to GA through interviews
with proxies of cases, and 5 studies used medical
records to determine exposure. Two studies used inci-
dent cases of dementia from cohort studies and expo-
sure to GA was determined through interviews of
individuals prior to them developing AD.
Assessment of Risk of Bias
The potential risk of bias associated with various aspects
of study design is described in Additional File 4, Table S2.
Four studies were rated as being at overall low risk of bias
[32,33,36,37] with the remaining studies being at higher
potential risk of bias due to some aspect of study design.
Figure 1 Flow of Studies through Review Process.
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Association between Exposure to Any Surgery with General
Anesthetic and Alzheimer’s Disease
All of the 15 studies included in the systematic review
controlled for age and gender and were subsequently
suitable to combine in meta-analysis. The association
between exposure to GA and risk of AD for each of the
studies is summarized in Additional File 5, Table S3.
Meta-analysis of the 15 studies revealed no statistically
significant association between previous exposure to GA
and development of AD (pooled OR = 1.05; 95% CI:
0.93 - 1.19: Z = 0.80, p = 0.43) (Figure 2). There was lit-
tle evidence of statistical heterogeneity between studies
as assessed by the Q statistic (Q = 9.76, df = 14, p =
0.78) and the magnitude of statistical heterogeneity was
minimal (I
2 = 0.0%).
Subgroup Analysis
Exposure to General Anesthesia Compared to Regional
Anesthesia
A total of two studies reported on the risk of AD asso-
ciated with GA and regional anesthesia[26,30]. The OR
for AD associated with exposure to GA was 1.06 (95%
CI: 0.64 -1.74, p = 0.83) in these two studies (Figure 3).
The OR for AD associated with previous exposure to
regional anesthesia was 0.68 (95% CI: 0.4 - 1.14, p =
0.14). The difference in the odds ratios was not statisti-
cally significant (Q = 0.55, df = 1, p = 0.46).
Number of Prior Anesthetics or Cumulative Exposure to
General Anesthesia
One study reported on the association between number
of anesthetics and the cumulative duration of anesthesia
and AD[31]. There was no statistically significant asso-
ciation between the number of surgeries involving GA
or cumulative exposure to GA. The OR for exposure to
six or more surgeries under general compared to fewer
than six was 1.44 (95% CI: 0.77 - 2.71) and the associa-
tion between a cumulative duration of greater than 10
hours of exposure to GA when compared to less than
10 hours was 1.63 (95% CI: 0.53 - 5.04).
Studies with Low Risk of Bias Compared to High Risk of
Bias
A total of four studies [32,33,36,37] were rated as being
at overall low risk of bias according to our risk of bias
assessment. The OR for exposure to GA and risk of AD
in these low risk of bias studies was 1.09 (95% CI: 0.93 -
1.28; Z = 1.05, p = 0.29) while the OR in the high risk
of bias studies was 1.00 (95%CI: 0.82 - 1.21; Z = 0.03, p
Figure 2 Forest Plot of Any Exposure to General Anesthesia and Alzheimer’s Disease.
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in the OR between the high and low risk of bias studies
(Q = 0.83, df = 1, p = 0.36).
Criteria for Defining Dementia
Eight studies used standardized criteria for diagnosing
AD [27,28,30-35] and seven studies used clinical criteria
or other methods for diagnosing AD [24-26,29,36,38,39].
The OR for exposure to GA and development of AD in
studies that used standard criteria was 1.06 (95% CI:
0.84 - 1.33, p = 0.63) and the OR for GA and AD in the
remaining studies was 1.05 (95% CI: 0.90 - 1.22, p =
0.53). There was no significant difference in the OR for
these subgroups (Q = 0.13, df = 1, p = 0.72.).
Type of Surgery
There were no studies included in our review that speci-
fied the type of surgery that was performed under gen-
eral anesthesia so no subgroup analyses could be
undertaken.
Time Between Exposure to General Anesthesia and
Assessment of Outcome
Only one study [25] specified a minimum duration of 5
years between exposure to GA and AD with an OR of
0.61 (0.22 - 1.63) while the remaining studies did not
report the duration of time elapsed between GA expo-
sure and assessment of dementia.
Sensitivity Analysis and Meta-Regression
The OR for exposure to any GA and AD was not statis-
tically significant when calculated after each study was
sequentially excluded. In addition, the summary OR did
not change after excluding the two studies that used
stepwise regression to adjust for confounders[35,38]
when compared to studies that explicitly matched or
adjusted for a minimum of age and gender.
There was no significant association observed between
the log OR and year of publication in meta-regression.
To investigate the potential effect that additional studies
would have had on our results, we calculated the
Orwin’s failsafe N to determine the number of studies
of a given effect size that would be required to change
the observed OR by a given amount. We selected a
mean observed OR for a hypothetical group of missing
studies to be 1.3 based on the observed upper range of
the ORs in the studies identified in our review. Assum-
ing a minimal clinically significant OR of 1.2 for the
association between GA and AD, an additional 25 stu-
d i e s ,e a c hw i t ham e a no b s e r v e dO Ro f1 . 3 ,w o u l db e
needed to arrive at an statistically significant OR of 1.2.
Publication Bias
There was no evidence of potential publication bias as
assessed by visual inspection of the funnel plot produced
by plotting the standard error against the log OR of
studies.
Discussion
This is the first systematic review and meta-analysis of
observational studies examining the association between
exposure to GA and risk of developing AD. We found a
number of case-control studies and no cohort studies
that examined the association between GA and develop-
ment of AD. Meta-analysis did not reveal any associa-
tion between previous exposure to GA and development
of AD. This finding was supported by several subgroup
and sensitivity analyses. However, many of the studies
included in our review were at some potential risk of
bias from certain aspects of study design and the poten-
tial biases inherent in all observational studies may have
contributed to the observed findings.
The findings from our review are consistent with the
existing clinical literature on the lack of long-term cog-
nitive sequelae associated with exposure to GA.
Although cognitive dysfunction is common following
Figure 3 Forest Plot of General Anesthesia Compared to Regional Anesthesia and Risk of Alzheimer’s Disease.
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be attributed to the stress of surgery and recovery
[12,39] rather than any specific effects of anesthetic
technique. Large-scale studies have reported that the
prevalence of POCD in the week following non-cardiac
surgery is 25% with 9.9% of individuals continuing to
display cognitive dysfunction at 3 months following sur-
gery[4]. However, a randomized controlled trial compar-
ing GA to regional anesthesia in non-cardiac surgery
found little difference in persistent POCD associated
with different anesthetic techniques. In this study, regio-
nal anesthesia was associated with a non-statistically sig-
nificant difference in early POCD at day 7 (19.7% vs
12.5%), although the proportions of individuals with
POCD in the regional and GA groups were similar at 3
months (14.3% vs. 13.9%)[40]. This same study reported
that most individuals recovered cognitive function by 1
- 2 years following surgery[10], indicating that there is
little evidence of long-term cognitive consequences asso-
ciated with GA when compared to regional techniques.
Similar results have been reported in other randomized
controlled trials comparing GA to regional anesthesia in
the elderly[41] as well as observational studies[39]. Sys-
tematic reviews of POCD following non-cardiac surgery
identified limited evidence for long-term cognitive
effects of GA although there were relatively few well-
designed studies with follow-up times of sufficient dura-
tion to allow for the development of AD following expo-
sure to anesthesia[13,17]. POCD appears to be more
common following cardiac surgery when compared to
non-cardiac surgery likely due to factors such as cardio-
pulmonary bypass, intraoperative hypotension, and risk
factors which are common for both cardiovascular dis-
ease and cerebrovascular disease[42,43]. The relative
contribution of GA to POCD in cardiac surgery setting
is difficult to ascertain as many cardiac procedures can-
not be undertaken using regional anesthetic techniques.
In contrast to our review and previous prospective
studies, evidence from animal models and in vitro stu-
dies suggesting that exposure to GA may promote AD
processes. Animal studies have suggested that exposure
to the volatile anesthetic gas halothane may increase
amyloid deposition in transgenic mice while isoflurane
had little effect on amyloid deposition[6]. Another ani-
mal study found that sevoflurane was also associated
with increases in beta-amyloid in mouse models[44].
Increases in tau hyperphosphorylation have also been
observed with exposure to ether anesthesia[8]. Addi-
tional human tissue culture studies report that isoflur-
ane[7,45,46], desflurane[47], and sevoflurane[7] may also
be associated with increases in beta-amyloid related
pathology. In our review we were not able to ascertain
possible differential effects of individual anesthetic
agents. However, halothane is an older medication that
has largely been replaced by newer anesthetic agents
and our study did not find that there was any associa-
tion between year of publication and association
between GA and AD. To date, there have been no stu-
dies that have examined the effects of GA on AD
pathology in humans following typical exposure to GA
through either biomarkers or neuroimaging and the
results observed in these basic studies require further
confirmation from human studies to determine the clin-
ical significance of these findings.
The main strengths of our study include the rigorous
methods employed to identify studies and assessment of
potential risk of bias. The lack of association between
GA and risk of AD was robust to a number of subgroup
and sensitivity analyses. We did not observe any evi-
dence of publication bias in the studies included in our
review, which decreases the likelihood that our findings
were related to our method of selecting articles. Finally,
the observed lack of association between exposure to
GA and AD is not likely to be affected by confounding
related to factors associated with requiring a surgical
procedure as this would have been expected to show an
elevated risk of AD associated with GA which was not
observed.
There are potential limitations to our study. Recall
and information bias are problematic in all case-con-
trol studies and are potentially of greater importance
in case-control studies of conditions such as AD where
individuals cannot provide an accurate record of past
exposures. Other studies have shown that proxy repor-
ters can be used to determine exposure status in case-
control studies of neurological diseases although the
accuracy of reporting is dependent on the nature of
the exposure[48]. All of the studies included in our
review attempted to address this source of bias by
using proxy reporters for exposure history or using
medical records. In three of the studies included in
this review, the accuracy of proxy reporters for deter-
mining exposure history was assessed through agree-
ment between the history provided by controls with
normal cognition and proxy reporters of these controls
[24,28,32] with agreement between controls and
proxies of controls on history of exposure to GA in
the moderate range of agreement indicating that proxy
reports of exposure may be prone to bias. Other
important factors such as potential dose-response rela-
tionship were only available from one study and no
studies included information on the type of surgery
which may have an important impact on the subse-
quent risk of AD. Finally, some individuals with early
cognitive impairment or dementia may be less likely to
be offered surgical procedures which may have reduced
the apparent observed risk of AD associated with GA
in our review.
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At the present time there we found no evidence to sup-
port an association between exposure to GA and
increased risk of developing AD based on available
observational studies. Patients should be warned about
the potential long-term cognitive sequelae of undergoing
surgical procedures and efforts should be made to opti-
mize the perioperative care of older adults who are at
risk of delirium and postoperative cognitive decline. The
decision to use GA over other anesthetic techniques
should be made on the basis of the surgical procedure
and other clinical factors related to anesthetic choice.
Further long-term prospective cohort studies or rando-
mized controlled trials using biomarkers or neuroima-
ging modalities are required to further understand the
associations between GA and AD.
Additional material
Additional file 1: Document 1: Electronic Database Search Strategy.
Additional file 2: Document 2: Risk of Bias Assessment Tool -
Adapted from the Newcastle-Ottawa Risk of Bias Assessment for
Case-Control Studies.
Additional file 3: Table S1: Case-Control Studies Examining
Association between General Anesthesia and Alzheimer’s Disease.
Additional file 4: Table S2: Association between Exposure to
General Anesthesia and Alzheimer’s Disease in Case-Control
Studies.
Additional file 5: Table S3: Assessment of Risk of Bias in Included
Studies.
Abbreviations
AD: Alzheimer’s disease; CI: confidence interval; GA: general anesthesia; OR:
odds ratio; POCD: postoperative cognitive decline; RA: regional anesthesia.
Acknowledgements
Dr. Seitz was supported by a Post Doctoral Fellowship Award from the
Alzheimer Society of Canada. This work was presented in abstract form at
the Canadian Academy of Geriatric Psychiatry Annual General Meeting on
September 18, 2010 in Toronto, Ontario, Canada.
Author details
1Department of Psychiatry, Queen’s University, Kingston, Ontario, Canada.
2Department of Pediatrics and Health Policy, Management, and Evaluation,
University of Toronto, Toronto, Ontario, Canada.
3Department of Psychiatry,
University of Toronto and Sunnybrook Health Sciences Centre, Toronto,
Ontario, Canada.
4Department of Clinical Epidemiology and Biostatistics,
McMaster University, Hamilton, Ontario, Canada.
5Department of Anesthesia,
Mount Sinai Hospital, Toronto, Ontario, Canada.
Authors’ contributions
DS and NS completed the literature search, data extraction, data analysis
and drafted the manuscript. PS contributed to the study conception, data
analysis and revising the manuscript. NH contributed to the study
conception, data analysis, data interpretation and revising the manuscript. JB
contributed to the data analysis and interpretation of data, and revising the
manuscript. All authors have given final approval to the version being
published.
Competing interests
The authors declare that they have no competing interests.
Received: 13 June 2011 Accepted: 14 December 2011
Published: 14 December 2011
References
1. Alzheimer Association: 2009 Alzheimer’s disease facts and figures.
Alzheimer Dement 2009, 5:234-270.
2. Querforth HW, LaFerla FM: Alzheimer’s Disease Mechanisms of Disease. N
Engl J Med 2010, 362:329-344.
3. Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C,
Sadovnick AD: Diagnosis and treatment of dementia: 1. Risk assessment
and primary prevention of Alzheimer disease. CMAJ 2008, 178:48-56.
4. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J,
Rabbit P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T,
Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH,
Beneken JE, Gravenstein JS: Long-term postoperative cognitive
dysfunction in the elderly ISPOCD1 study. ISPOCD investigators.
International Study of Post-Operative Cognitive Dysfunction. Lancet 1998,
351:857-61.
5. Bilotta F, Doronzio A, Stazi E, Titi L, Fodale V, Di Nino G, Rosa G:
Postoperative cognitive dysfunction: toward the Alzheimer’s disease
pathomechanism hypothesis. J Alzheimers Dis 2010, 22(Suppl 3):81-9.
6. Bianchi SL, Tran T, Liu C, Lin S, Li Y, Keller JM, Eckenhoff RG, Eckenhoff MF:
Brain and behavior changes in 12-month-old Tg2576 and nontransgenic
mice exposed to anesthetics. Neurobiol Aging 2008, 29:1002-10.
7. Xie Z, Dong Y, Maeda U, Alfille P, Cully DJ, Crosby G, Tanzi RE: The
common inhalation anesthetic isoflurane induces apoptosis and
increases amyloid beta protein levels. Anesthesiology 2006, 104:988-94.
8. Ikeda Y, Ishiguro K, Fujita SC, Ikeda Y, Ishiguro K, Fujita S: Ether stress-
induced Alzheimer-like tau phosphorylation in the normal mouse brain.
FEBS Letters 2007, 581:891-7.
9. Planel E, Richter KE, Nolan CE, Finley JE, Liu L, Wen Y, Krishnamurthy P,
Herman M, Wang L, Schachter JB, Nelson RB, Lau LF, Duff KE: Anesthesia
leads to tau hyperphosphorylation through inhibition of phosphatase
activity by hypothermia. J Neurosci 2007, 27:3090-7.
10. Abildstrom H, Rasmussen LS, Rentowl P, Hanning CD, Rasmussen H,
Kristensen PA, Moller JT: Cognitive dysfunction 1-2 years after non-
cardiac surgery in the elderly. ISPOCD group. International Study of
Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand 2000,
44:1246-51.
11. Baranov D, Bickler PE, Crosby GJ, Culley DJ, Eckenhoff MF, Eckenhoff RG,
Hogan KJ, Jevtovic-Todorovic V, Palotas A, Perouansky M, Planel E,
Silverstein JH, Wei H, Whittington RA, Xie Z, Zuo Z: Consensus statement:
First International Workshop on Anesthetics and Alzheimer’s disease.
Anesth Analg 2009, 108:1627-30.
12. Cryns AG, Gorey KM, Goldstein MZ: Effects of surgery on the mental
status of older persons. A meta-analytic review. J Geriatr Psychiatry Neurol
1990, 3:184-91.
13. Newman S, Stygall J, Hirani S, Shaefi S, Maze M: Postoperative cognitive
dysfunction after noncardiac surgery: a systematic review. Anesthesiology
2007, 106:572-90.
14. Parker MJ, Handoll HHG, Griffiths R: Anaesthesia for hip fracture surgery in
adults. Cochrane Database Syst Rev 2009, 4:CD000521.
15. Bryson GL, Wyand A: Evidence-based clinical update: general anesthesia
and the risk of delirium and postoperative cognitive dysfunction. Can J
Anaesth 2006, 53:669-77.
16. Wu CL, Hsu W, Richman JM, Raja SN: Postoperative cognitive function as
an outcome of regional anesthesia and analgesia. Reg Anesth Pain Med
2004, 29:257-68.
17. Mason SE, Noel-Storr A, Ritchie CW: The impact of general and regional
anesthesia on the incidence of post-operative cognitive dysfunction and
post-operative delirium: a systematic review with meta-analysis. J
Alzheimers Dis 2010, 22(Suppl 3):67-79.
18. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D,
Becker BJ, Sipe TA, Thacker SB: Meta-Analysis of Observational Studies in
Epidemiology: A Proposal for Reporting. JAMA 2000, 283:2008-2012.
19. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group: Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA
Statement. PLOS Med 2009, 6:e1000097.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM:
Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA
Seitz et al. BMC Geriatrics 2011, 11:83
http://www.biomedcentral.com/1471-2318/11/83
Page 7 of 8Work Group under the auspices of Department of Health and Human
Services Task Force on Alzheimer’s Disease. Neurology 1984, 34:939-944.
21. American Psychiatric Association: Diagnostic and Statistical Manual of
Mental Disorders.Edited by: Arlington VA. American Psychiatric Association;
, Fourth 2000:, Text Revision.
22. von Elm E, Altman D, Egger M, Pocock SJ, Gotzsche PC, Vandenbrouke JP:
The Strengthening of Reporting of Observational Studies in
Epidemiology Statement: Guidelines for Reporting Observational
Studies. PLoS Med 2007, 4:e296.
23. Ottawa Health Research Institute: The Newcastle-Ottawa Scale (NOS) for
assessing the quality of non-randomized studies in meta-analysis.[http://
www.ohri.ca/programs/clinical_epidemiology/oxford.htm].
24. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg :
Alzheimer’s Disease: A Study Epidemiological Aspects. Ann Neurol 1984,
15:335-341.
25. French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B:
A case-control study of dementia of the Alzheimer type. Am J Epidemiol
1985, 21:414-21.
26. Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D,
Bracco L, Lippi A: Risk factors for clinically diagnosed Alzheimer’s disease:
a case-control study of an Italian population. Neurology 1986, 36:922-31.
27. Broe GA, Henderson SA, Creasey H, McCusker E, Korten AE, Jorm AF,
Longley W, Anthony JC: A case-control study of Alzheimer’s disease in
Australia. Neurology 1990, 40:1698-707.
28. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB,
Raskind M: A case-control study of Alzheimer’s disease. Ann Neurol 1990,
28:766-74.
29. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ:
Clinical risk factors for Alzheimer’s disease: a population-based case-
control study. Neurology 1991, 41:1393-7.
30. Li G, Shen YC, Li YT, Chen CH, Zhau YW, Silverman JM: A case-control
study of Alzheimer’s disease in China. Neurology 1992, 42:1481-8.
31. Bohnen NI, Warner MA, Kokmen E, Beard CM, Kurland LT: Alzheimer’s
disease and cumulative exposure to anesthesia: a case-control study. J
Am Geriatr Soc 1994, 42:198-201.
32. The Canadian Study of Health and Aging: The Canadian Study of Health
and Aging: Risk factors for Alzheimer’s disease in Canada. Neurology 1994,
44:2073-2080.
33. Tyas SL, Manfreda J, Strain LA, Montgomery PR: Risk factors for Alzheimer’s
disease: a population-based, longitudinal study in Manitoba, Canada. Int
J Epidemiol 2001, 30:590-7.
34. Gasparini M, Vanacore N, Schiaffini C, Brusa L, Panella M, Talarico G,
Bruno G, Meco G, Lenzi GL: Neurolog A case-control study on Alzheimer’s
disease and exposure to anesthesia. Neurol Sci 2002, 23:11-4.
35. Harmanci H, Emre M, Gurvit H, Bilgic B, Hanagasi H, Gurol E, Sahin H,
Tinaz S: Risk factors for Alzheimer disease: a population-based case-
control study in Istanbul, Turkey. Alzheimer Dis Assoc Disord 2003,
17:139-45.
36. Yip AG, Brayne C, Matthews FE: Risk factors for incident dementia in
England and Wales: The Medical Research Council Cognitive Function
and Ageing Study. A population-based nested case-control study. Age
Ageing 2006, 35:154-60.
37. Plassman BL, Langa KM, Finlayson EVA, Rogers MAM: Surgery using
general anesthesia and risk of dementi in the Aging, Demographics and
Memory Study, in International Conference on Alzheimer’s Dementia.
2009.
38. Zuo C, Zuo Z: Spine Surgery under General Anesthesia May Not Increase
the Risk of Alzheimer’s Disease. Dement Geriatr Cogn Disord 2010,
29:233-239.
39. Ancelin M-L, de Roquefeuil G, Scali J, Bonnel J, Adam JF, Cheminal JC,
Cristol JP, Dupuy A-M, Carriere I, Ritchie K: Long-term post-operative
cognitive decline in the elderly: the effects of anesthesia type,
apolipoprotein E genotype, and clinical antecedents. J Alzheimers Dis
2010, 22(Suppl 3):105-13.
40. Rasmussen LS, Johnson T, Kuipers HM, Kristensen D, Siersma VD, Vila P,
Jolles J, Papioannou A, Abildstrom H, Silverstein JH, Bonal JH, Raeder J,
Nielson IK, Korttila K, Munoz L, Dodds C, Moller JT, Investigators IPOCD:
Does anaesthesia cause postoperative cognitive dysfunction? A
randomised study of regional versus general anaesthesia in 438 elderly
patients. Acta Anaesthesiol Scand 2003, 47:260-6.
41. Nielson WR, Gelb AW, Casey JE, Penny FJ, Merchant RN, Manninen PH:
Long-term cognitive and social sequelae of general versus regional
anesthesia during arthroplasty in the elderly. Anesthesiology 1990,
73:1103-9.
42. Gao L, Taha R, Gauvin D, Othmen LB, Wang Y, Blaise G: Postoperative
cognitive dysfunction after cardiac surgery. Chest 2005, 128:3664-70.
43. Mehta Y, Singh R: Cognitive dysfunction after cardiac surgery. J Alzheimers
Dis 2010, 22(Suppl 3):115-20.
44. Dong Y, Zhang G, Zhang B, Moir RD, Xia W, Marcantonio ER, Culley DJ,
Crosby G, Tanzi RE, Xie Z: The common inhalational anesthetic
sevoflurane induces apoptosis and increases beta-amyloid protein levels.
Arch Neurol 2009, 66:620-31.
45. Xie Z, Dong Y, Maeda U, Moir R, Inouye SK, Inouye SK, Culley DJ, Crosby G,
Tanzi RE: Isoflurane-induced apoptosis: a potential pathogenic link
between delirium and dementia. J Gerontol A Biol Sci Med Sci 2006,
61:1300-6.
46. Xie Z, Dong Y, Maeda U, Moir D, Xia W, Culley DJ, Crosby G, Tanzi RE: The
inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and
amyloid beta-protein accumulation. J Neurosci 2007, 27:1247-54.
47. Zhang B, Dong Y, Zhang G, Moir RD, Xia W, Yue Y, Tian M, Culley DG,
Crosby G, Tanzi RE: The inhalation anesthetic desflurane induces caspase
activation and increases amyloid beta-protein levels under hypoxic
conditions. J Biol Chem 2008, 283:11866-75.
48. Rocca WA, Fratiglioni L, Bracco L, Pedone D, Groppi C, Schoenberg BS: The
use of surrogate respondents to obtain questionnaire data in case-
control studies of neurologic diseases. J Chron Dis 1986, 39:907-12.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2318/11/83/prepub
doi:10.1186/1471-2318-11-83
Cite this article as: Seitz et al.: Exposure to general anesthesia and risk
of alzheimer’s disease: a systematic review and meta-analysis. BMC
Geriatrics 2011 11:83.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Seitz et al. BMC Geriatrics 2011, 11:83
http://www.biomedcentral.com/1471-2318/11/83
Page 8 of 8